Search Results

Five-Year Data Published for Terumo's Nobori DES With Biodegradable Polymer

December 23, 2014—Bernard Chevalier, MD, et al published the 5-year clinical outcome data of the Nobori coronary drug-eluting stent (DES) system (Terumo Interventional Systems) in the treatment of patients with coronary artery disease.

Findings Reported for FANTOM II Study of Reva Medical's Bioresorbable Scaffold

June 10, 2019—Twelve-month follow-up data from the FANTOM II study were published by Bernard Chevalier, MD, et al online in Circulation: Cardiovascular Interventions.

ABSORB II 2-Year Data Published for Abbott Vascular's Absorb BVS

October 24, 2016—The 2-year clinical outcomes of the ABSORB II trial were published by Bernard Chevalier, MD, et al in EuroIntervention (2016;12:1102–1107).

Colibri Heart Valve Announces First Patients Enrolled in TAVI System Pilot Study

November 3, 2021—Colibri Heart Valve LLC announced the initiation of an international, CE Mark-enabling pilot study of the Colibri transcatheter aortic valve implantation (TAVI) system.

Two-Year ABSORB II Data Presented for Abbott Vascular's BVS

October 12, 2015—Two-year follow-up data from ABSORB II, the first randomized study comparing everolimus-eluting bioresorbable vascular stents (BVS) and metallic everolimus-eluting stents (EES) showed similar patient-oriented clinical outcomes for both devices, according to a presentation at the TCT 2015, the 27th annual Transcatheter Cardiovascular Therapeutics scientific symposium, being held October 11–15 in San Francisco, California.